DrugPatentWatch.com Announces New Drug Patent Expiration Website
New website features detailed information on pharmaceutical drugs and their patent expirations
Washington, DC, October 28, 2009 --(PR.com)-- DrugPatentWatch.com announces a new website featuring detailed information on pharmaceutical drugs and their patent expirations.
This new website features comprehensive information on pharmaceutical companies, their products, and the patents covering them.
Datasets include:
- Impending drug patent expirations
- Annual sales
- Drug therapeutic class
- Paragraph IV challenges
- Premature patent expiration due to lack of maintenance fee payment
- Patent reexaminations
- Patent interferences
- Patent disclaimers
- Full-text drug patent PDFs
- Drug patent claim types (use, compound, formulation, etc.)
Detailed previews and a site tour are available at http://www.DrugPatentWatch.com
###
About DrugPatentWatch.com
DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. This value-added information supports the critical business functions of patent agents and attorneys, generic and branded pharmaceutical companies, wholesalers, healthcare payers, and investors.
This new website features comprehensive information on pharmaceutical companies, their products, and the patents covering them.
Datasets include:
- Impending drug patent expirations
- Annual sales
- Drug therapeutic class
- Paragraph IV challenges
- Premature patent expiration due to lack of maintenance fee payment
- Patent reexaminations
- Patent interferences
- Patent disclaimers
- Full-text drug patent PDFs
- Drug patent claim types (use, compound, formulation, etc.)
Detailed previews and a site tour are available at http://www.DrugPatentWatch.com
###
About DrugPatentWatch.com
DrugPatentWatch provides information on drug patent expirations. Complete details are provided for all FDA-approved small molecule drugs. This value-added information supports the critical business functions of patent agents and attorneys, generic and branded pharmaceutical companies, wholesalers, healthcare payers, and investors.
Contact
DrugPatentWatch.com
Yali Friedman
202-487-0089
www.DrugPatentWatch.com
Contact
Yali Friedman
202-487-0089
www.DrugPatentWatch.com
Categories